Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Blood|January 9, 2025
Genetic subtypes of B-cell acute lymphoblastic leukemia in adultsMarie Passet, Rathana Kim, Emmanuelle Clappier
Molecular Biology Reports|August 12, 2021
KMT2A-ARHGEF12, a therapy related fusion with poor prognosisNada Assaf, Raphael Liévin, Fatiha Merabet, et al.
Seminars in Hematology|December 4, 2018
Cerebrospinal fluid interleukin (IL)-10 and IL-10:IL-6 ratio as biomarkers for small B-cell lymphoproliferations with leptomeningeal disseminationMyrto Costopoulos, Rathana Kim, Sylvain Choquet, et al.
Blood|April 6, 2023
IL-7 receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK inhibitionLucien Courtois, Aurélie Cabannes-Hamy, Rathana Kim, et al.
Cytometry. Part B, Clinical Cytometry|November 27, 2024
Prospective feasibility of a minimal BH3 profiling assay in acute myeloid leukemiaKim Pacchiardi, Victoire de Marcellus, Tony Huynh, et al.
Nature Communications|February 3, 2023
Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylationMaxime Boy, Valeria Bisio, Lin-Pierre Zhao, et al.
Molecular Cancer|July 5, 2024
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patientsLenka Hovorkova, Lucie Winkowska, Justina Skorepova, et al.
Leukemia|January 30, 2020
Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantationRathana Kim, Nicolas Boissel, Aurore Touzart, et al.
JAMA Dermatology|September 8, 2021
UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS SyndromeEve Zakine, Bérénice Schell, Maxime Battistella, et al.
Leukemia|June 26, 2020
Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapyMarco Cerrano, Matthieu Duchmann, Rathana Kim, et al.
Pageof 3